Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis

BMC Complementary and Alternative Medicine

Volumn 14, Issue , 2014, Pages

  Nousiainen, Pauliina ^a   Merras Salmio, Laura ^b   Aalto, Kristiina ^b   Kolho, Kaija Leena ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

Children; Colitis ulcerative; Crohn's disease; Juvenile idiopathic arthritis; Paediatric

Indexed keywords

ANTIBIOTIC AGENT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; MINERAL; MULTIVITAMIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROBIOTIC AGENT; TRACE ELEMENT; VITAMIN;

ACUPUNCTURE; ADOLESCENT; ADOLESCENT DISEASE; ADULT; ALTERNATIVE MEDICINE; ARTICLE; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ACTIVITY; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASE; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MASSAGE; OUTPATIENT; PATIENT COMPLIANCE; REFLEXOLOGY; TREATMENT RESPONSE; VITAMIN SUPPLEMENTATION; ARTHRITIS, JUVENILE; CHILD; DIET; DIET SUPPLEMENTATION; FINLAND; INFLAMMATORY BOWEL DISEASES; QUESTIONNAIRE; SELF CARE; SEVERITY OF ILLNESS INDEX; UTILIZATION;

ADOLESCENT; ARTHRITIS, JUVENILE; CHILD; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; DIET; DIETARY SUPPLEMENTS; FEMALE; FINLAND; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MICRONUTRIENTS; PROBIOTICS; QUESTIONNAIRES; SELF CARE; SEVERITY OF ILLNESS INDEX;

EID: 84897578531     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-124     Document Type: Article

References (37)

1. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012, 142(1):46-54. e42, 10.1053/j.gastro.2011.10.001, 22001864.
2. Lehtinen P, Ashorn M, Iltanen S, Jauhola R, Jauhonen P, Kolho KL, Auvinen A. Incidence trends of pediatric inflammatory bowel disease in Finland, 1987-2003, a nationwide study. Inflamm Bowel Dis 2011, 17(8):1778-1783. 10.1002/ibd.21550, 21744433.
3. Marcus SB, Strople JA, Neighbors K, Weissberg-Benchell J, Nelson SP, Limbers C, Varni JW, Alonso EM. Fatigue and health-related quality of life in pediatric inflammatory bowel disease. Clin Gastroenterol Hepatol 2009, 7(5):554-561. 10.1016/j.cgh.2009.01.022, 19418604.
4. Haapamaki J, Roine RP, Sintonen H, Kolho KL. Health-related quality of life in paediatric patients with inflammatory bowel disease related to disease activity. J Paediatr Child Health 2011, 47(11):832-837. 10.1111/j.1440-1754.2011.02034.x, 21435075.
5. Vaisto T, Aronen ET, Simola P, Ashorn M, Kolho KL. Psychosocial symptoms and competence among adolescents with inflammatory bowel disease and their peers. Inflamm Bowel Dis 2010, 16(1):27-35. 10.1002/ibd.21002, 19575356.
6. Mackner LM, Greenley RN, Szigethy E, Herzer M, Deer K, Hommel KA. Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2013, 56(4):449-458. 10.1097/MPG.0b013e3182841263, 3609923, 23287808.
7. Castaneda AE, Tuulio-Henriksson A, Aronen ET, Marttunen M, Kolho KL. Cognitive functioning and depressive symptoms in adolescents with inflammatory bowel disease. World J Gastroenterol 2013, 19(10):1611-1617. 10.3748/wjg.v19.i10.1611, 3602478, 23538788.
8. Wilson DC, Thomas AG, Croft NM, Newby E, Akobeng AK, Sawczenko A, Fell JM, Murphy MS, Beattie RM, Sandhu BK, Mitton SG, Casson D, Elawad M, Heuschkel R, Jenkins H, Johnson T, Macdonald S, Murch SH, IBD Working Group of the British Society of Paediatric Gastroenterology, Hepatology, and Nutrition Systematic review of the evidence base for the medical treatment of paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2010, 50(Suppl 1):S14-34. 10.1097/MPG.0b013e3181c92caa, 20081542, IBD Working Group of the British Society of Paediatric Gastroenterology, Hepatology, and Nutrition.
9. Virta LJ, Kolho KL. Trends in early outpatient drug therapy in pediatric inflammatory bowel disease in Finland: a nationwide register-based study in 1999-2009. ISRN Gastroenterol 2012, 2012:462642. 3431087, 22957263.
10. Berntson L, Andersson Gare B, Fasth A, Herlin T, Kristinsson J, Lahdenne P, Marhaug G, Nielsen S, Pelkonen P, Rygg M. Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol 2003, 30(10):2275-2282.
11. Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, Lahdenne P, Nielsen S, Straume B, Rygg M. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum 2011, 63(9):2809-2818. 10.1002/art.30426, 21560116.
12. Giancane G, Pederzoli S, Norambuena X, Ioseliani M, Sato J, Gallo MC, Negro G, Pistorio A, Ruperto N, Martini A, Ravelli A. Frequency of radiographic damage and progression in individual joints in children with juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2013, 66:27-33.
13. Shenoi S, Wallace CA. Remission in juvenile idiopathic arthritis: current facts. Curr Rheumatol Rep 2010, 12(2):80-86. 10.1007/s11926-010-0085-2, 20425015.
14. Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Martini A, Rabinovich CE, Ruperto N. American college of rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 2011, 63(4):465-482. 10.1002/acr.20460, 3222233, 21452260.
15. Opheim R, Hoivik ML, Solberg IC, Moum B. Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN). J Crohns Colitis 2012, 6(3):345-353. 10.1016/j.crohns.2011.09.007, 22405172.
16. Hagen LE, Schneider R, Stephens D, Modrusan D, Feldman BM. Use of complementary and alternative medicine by pediatric rheumatology patients. Arthritis Rheum 2003, 49(1):3-6. 10.1002/art.10931, 12579587.
17. Complementary, Alternative, or Integrative Health: What́s In a Name?. [http://nccam.nih.gov/health/whatiscam], accessed Nov 21, 2013.
18. Hilsden RJ, Verhoef MJ, Rasmussen H, Porcino A, DeBruyn JC. Use of complementary and alternative medicine by patients with inflammatory bowel disease. Inflamm Bowel Dis 2011, 17(2):655-662. 10.1002/ibd.21360, 20848543.
19. Bunchorntavakul C, Reddy KR. Review article: herbal and dietary supplement hepatotoxicity. Aliment Pharmacol Ther 2013, 37(1):3-17. 10.1111/apt.12109, 23121117.
20. Otley AR, Verhoef MJ, Best A, Hilsden RJ. Prevalence and determinants of use of complementary and alternative medicine in a Canadian pediatric inflammatory bowel disease (IBD) population. Gastroenterology 2001, 120(5 (Supplement 1))):A213.
21. Gerasimidis K, McGrogan P, Hassan K, Edwards CA. Dietary modifications, nutritional supplements and alternative medicine in paediatric patients with inflammatory bowel disease. Aliment Pharmacol Ther 2008, 27(2):155-165.
22. Heuschkel R, Afzal N, Wuerth A, Zurakowski D, Leichtner A, Kemper K, Tolia V, Bousvaros A. Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol 2002, 97(2):382-388. 10.1111/j.1572-0241.2002.05474.x, 11866277.
23. Markowitz JE, Mamula P, delRosario JF, Baldassano RN, Lewis JD, Jawad AF, Culton K, Strom BL. Patterns of complementary and alternative medicine use in a population of pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2004, 10(5):599-605. 10.1097/00054725-200409000-00015, 15472521.
24. Wong AP, Clark AL, Garnett EA, Acree M, Cohen SA, Ferry GD, Heyman MB. Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey. J Pediatr Gastroenterol Nutr 2009, 48(1):55-60. 10.1097/MPG.0b013e318169330f, 3250599, 19172124.
25. Day AS, Whitten KE, Bohane TD. Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease. J Paediatr Child Health 2004, 40(12):681-684. 10.1111/j.1440-1754.2004.00510.x, 15569284.
26. Feldman DE, Duffy C, De Civita M, Malleson P, Philibert L, Gibbon M, Ortiz-Alvarez O, Dobkin PL. Factors associated with the use of complementary and alternative medicine in juvenile idiopathic arthritis. Arthritis Rheum 2004, 51(4):527-532. 10.1002/art.20536, 15334423.
27. Zebracki K, Holzman K, Bitter KJ, Feehan K, Miller ML. Brief report: use of complementary and alternative medicine and psychological functioning in Latino children with juvenile idiopathic arthritis or arthralgia. J Pediatr Psychol 2007, 32(8):1006-1010. 10.1093/jpepsy/jsm033, 17626068.
28. April KT, Feldman DE, Zunzunegui MV, Descarreaux M, Malleson P, Duffy CM. Longitudinal analysis of complementary and alternative health care use in children with juvenile idiopathic arthritis. Complement Ther Med 2009, 17(4):208-215. 10.1016/j.ctim.2009.03.003, 19632548.
29. Rouster-Stevens K, Nageswaran S, Arcury TA, Kemper KJ. How do parents of children with juvenile idiopathic arthritis (JIA) perceive their therapies?. BMC Complement Altern Med 2008, 8:25. 10.1186/1472-6882-8-25, 2424030, 18518962.
30. Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, Malattia C, Viola S, Martini A, Ravelli A. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 2009, 61(5):658-666. 10.1002/art.24516, 19405003.
31. Birdee GS, Phillips RS, Davis RB, Gardiner P. Factors associated with pediatric use of complementary and alternative medicine. Pediatrics 2010, 125(2):249-256. 10.1542/peds.2009-1406, 3057373, 20100769.
32. Davis MP, Darden PM. Use of complementary and alternative medicine by children in the United States. Arch Pediatr Adolesc Med 2003, 157(4):393-396. 10.1001/archpedi.157.4.393, 12695237.
33. April KT, Walji R. The state of research on complementary and alternative medicine in pediatric rheumatology. Rheum Dis Clin North Am 2011, 37(1):85-94. 10.1016/j.rdc.2010.11.011, 21220088.
34. Li FX, Verhoef MJ, Best A, Otley A, Hilsden RJ. Why patients with inflammatory bowel disease use or do not use complementary and alternative medicine: a Canadian national survey. Can J Gastroenterol 2005, 19(9):567-573.
35. Weizman AV, Ahn E, Thanabalan R, Leung W, Croitoru K, Silverberg MS, Steinhart AH, Nguyen GC. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease. Aliment Pharmacol Ther 2012, 35(3):342-349. 10.1111/j.1365-2036.2011.04956.x, 22176478.
36. Quattropani C, Ausfeld B, Straumann A, Heer P, Seibold F. Complementary alternative medicine in patients with inflammatory bowel disease: use and attitudes. Scand J Gastroenterol 2003, 38(3):277-282.
37. Teschke R, Schulze J, Schwarzenboeck A, Eickhoff A, Frenzel C. Herbal hepatotoxicity: suspected cases assessed for alternative causes. Eur J Gastroenterol Hepatol 2013, 46:264-269.